What Is Ozempic? Everything You Should Know Before Starting

Ozempic at a glance:

• Drug class: GLP-1 receptor agonist
• Manufacturer: Novo Nordisk
• FDA approved: 2017
• Route: subcutaneous injection (multi-dose pen)
• Typical frequency: once weekly
• Half-life: approximately 7 days (allows once-weekly dosing)
• Cash price (US): $950-$1,000/month without insurance
• Receptor target: GLP-1 receptor

Let's cut through the marketing on Ozempic and look at what the data actually say. Ozempic is the brand name for semaglutide approved for type 2 diabetes, and the result for users is: a1c reductions of 1.5-1.8% and weight loss averaging 4-6 kg in sustain trials. reduced major adverse cardiovascular events in sustain-6.

What is Ozempic?

Ozempic is the brand name for semaglutide approved for type 2 diabetes. Semaglutide is a long-acting GLP-1 receptor agonist that increases insulin secretion in response to food, suppresses glucagon, slows gastric emptying, and reduces appetite.

Ozempic is manufactured by Novo Nordisk and is a brand name for the generic compound semaglutide. Ozempic was approved by the FDA in 2017. Its approved indications include type 2 diabetes, cardiovascular risk reduction in T2D. Off-label use happens in clinical practice but is the prescriber's responsibility.

The drug class glp-1 receptor agonist works by acting at the GLP-1 receptor. We cover the details below.

How Ozempic Works in the Body

Ozempic is the brand name for semaglutide approved for type 2 diabetes. Semaglutide is a long-acting GLP-1 receptor agonist that increases insulin secretion in response to food, suppresses glucagon, slows gastric emptying, and reduces appetite. The receptor target — GLP-1 receptor — drives the downstream effects users care about: a1c reductions of 1.5-1.8% and weight loss averaging 4-6 kg in sustain trials. reduced major adverse cardiovascular events in sustain-6.

The pharmacokinetics matter for daily use. Ozempic has a half-life of approximately 7 days (allows once-weekly dosing), which determines how often it is dosed. The standard route of administration is subcutaneous injection (multi-dose pen), and the typical schedule is once weekly.

For more detail on the underlying biology, see our breakdown of how Ozempic works.

Who Uses Ozempic?

Ozempic is most relevant for people whose situation maps to its approved indications: type 2 diabetes; cardiovascular risk reduction in T2D. Off-label uses include weight loss (off-label; the same drug is approved for weight loss as Wegovy).

People who should avoid Ozempic include those with the following:

• personal or family history of medullary thyroid carcinoma
• MEN 2 syndrome

Common and Serious Side Effects

The most commonly reported side effects of Ozempic include:

• nausea
• diarrhea
• vomiting
• constipation
• abdominal pain
• fatigue

Serious risks — uncommon but worth knowing — include:

• pancreatitis
• gallbladder disease
• diabetic retinopathy worsening
• thyroid C-cell tumors (boxed warning)
• acute kidney injury

We have a more detailed breakdown in our Ozempic side-effects guide.

Ozempic vs Alternatives

Common alternatives include Mounjaro (tirzepatide, often more weight loss), Trulicity (dulaglutide, also weekly), and Wegovy (same molecule, weight-loss indication). If you are weighing Ozempic against another option, our comparison pages include Is Ozempic Safe? An Honest Look at the Side-Effect Profile, Ozempic Results: Realistic Expectations vs. Trial Headlines, Ozempic Cost Explained: Monthly, Yearly, and How to Save.

Bottom Line

If you're considering Ozempic, the most useful next step is usually a conversation with a clinician who knows the full landscape of options — not just the one they prescribe most often. Multiple randomized controlled trials support its efficacy. If you are considering Ozempic, talk to a licensed clinician first — particularly if you take other medications.

Frequently Asked Questions

Related Reading

• Is Ozempic Safe? An Honest Look at the Side-Effect Profile
• Ozempic Results: Realistic Expectations vs. Trial Headlines
• Ozempic Cost Explained: Monthly, Yearly, and How to Save
• Getting Ozempic Dosing Right: A Step-by-Step Walkthrough
• Ozempic Before and After: A Week-by-Week Realistic Timeline
• Ozempic Benefits: What the Evidence Actually Supports

Sources

• Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM 2023;389:2221.
• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989.
• Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (SUSTAIN-6). NEJM 2016;375:1834.

This page is informational only and is not medical advice. Consult a licensed clinician before starting, stopping, or changing any medication.